U.S. Contraceptive Market Size, Share, Growth Analysis, By Product(Pills, Intrauterine Devices (IUD) (Hormonal IUD), By Age-group(15-44 years, above 44 years), By End-User(Households, clinics) - Industry Forecast 2024-2031

US Contraceptive Market size was valued at USD 7.88 billion in 2019 and is poised to grow from USD 8.3 billion in 2023 to USD 12.15 billion by 2031, growing at a CAGR of 5.16% in the forecast period (2024-2031).

Contraception, or birth control, is the use of medications, devices, or surgery to prevent pregnancy. Some of them are reversible, while others are irreversible. Some varieties can also aid in the prevention of sexually transmitted infections (STDs). Increased usage of contemporary contraceptives and increased knowledge of sexual health and family planning among teenagers and the young population are significant factors driving market expansion in the United States. Furthermore, government initiatives have increased access to contraceptives, which aid in the prevention of unplanned births in teens. According to the Guttmacher Institute, 60% of women of reproductive age in the United States utilize contraception. Among married women, the use of hormonal contraceptives other than the birth control pill has grown dramatically.

The increased availability of contraception in the United States has benefited various elements of society, including women's education, professional possibilities, and poverty. Access to contemporary contraceptive techniques has substantially increased job options for women and allowed them to earn pay on par with males. It has also decreased the number of women living in poverty as a result of unwanted pregnancies and the high expenditures of childrearing. The legalisation of family planning in the majority of states has lowered the economic burden for the next generation, since the number of persons living in poverty as adults have decreased significantly.

US Contraceptive Market is poised to grow at a sustainable CAGR for the next forecast year.